# Business Requirements Document (BRD)
## SymptoMap: AI-Powered Disease Intelligence & Surveillance Platform
**Version:** 2.0 (Evolution from V1)
**Date:** June 2026

---

## 1. Executive Summary

### What the Platform Does
SymptoMap is an enterprise-grade AI-powered disease intelligence and surveillance platform. Built upon the foundation of its Version 1 interactive outbreak mapping tool, SymptoMap V2 evolves into a comprehensive, real-time epidemiological intelligence engine. The platform is capable of ingesting vast amounts of healthcare and public health data, analyzing it through advanced machine learning algorithms (such as SEIR modeling and time-series forecasting), visualizing disease spread through high-fidelity geospatial heatmaps, and proactively monitoring regional disease outbreaks. It provides end-to-end capabilities from data collection by ground-level healthcare workers to predictive risk assessments for national government decision-makers.

### Why it is Needed
Historically, public health surveillance has been reactive, relying on delayed reporting cycles, fragmented systems, and manual epidemiological tracing. When outbreaks occur, the latency between an initial localized cluster and a coordinated public health response often leads to uncontained spread, overwhelming healthcare infrastructure. SymptoMap bridges this critical gap by providing real-time data ingestion, automated anomaly detection, and predictive modeling, allowing for proactive, rather than reactive, public health management.

### Expected Impact
By integrating real-time surveillance with predictive analytics, SymptoMap will drastically reduce the time to detect emerging disease vectors. The platform will enable public health authorities to optimize resource allocation (e.g., medical supplies, vaccines, and personnel) ahead of peak infection periods, ultimately saving lives, reducing economic burdens, and preventing localized outbreaks from escalating into regional or global pandemics.

### Key Business Value
- **Operational Efficiency:** Automates manual data collation and reporting workflows, freeing epidemiologists to focus on analysis rather than data entry.
- **Risk Mitigation:** Proactively alerts stakeholders to impending health crises, allowing governments and hospitals to enact preventative measures.
- **Strategic Insight:** Delivers actionable, data-driven intelligence through executive dashboards that visualize complex epidemiological metrics in digestible formats.
- **Cost Reduction:** Minimizes the massive economic toll of widespread lockdowns and overwhelmed healthcare systems by facilitating targeted, localized interventions.

---

## 2. Problem Statement

Public health agencies and healthcare organizations face several critical challenges in the current landscape:

- **Delayed Outbreak Detection:** Traditional disease reporting relies on hierarchical, manual processes. By the time a local hospital reports an unusual spike in respiratory cases to a national health body, the pathogen may have already spread geographically.
- **Fragmented Healthcare Data:** Data exists in silos—hospitals use proprietary EHRs, labs use separate LIMS, and pharmacies track medication sales independently. There is no unified mechanism to correlate these disparate data points in real time.
- **Lack of Real-Time Monitoring:** Existing systems often update weekly or monthly. Disease spread, particularly for highly transmissible airborne or vector-borne pathogens, operates on an hourly or daily scale.
- **Poor Disease Forecasting:** Current epidemiological models are often run offline on static datasets. The lack of dynamic, real-time SEIR (Susceptible, Exposed, Infectious, Recovered) simulations leaves authorities guessing about the trajectory of an outbreak.
- **Manual Reporting Systems:** Healthcare workers are burdened with cumbersome paperwork or outdated digital forms, leading to underreporting, data entry errors, and significant delays.
- **Limited Epidemiological Visibility:** Decision-makers struggle to visualize the geographic spread of diseases. Without robust geospatial analytics, understanding the exact epicenter and diffusion pattern of a cluster is nearly impossible.
- **Slow Public Health Response:** As a result of the above, public health responses (e.g., deploying mobile clinics, issuing travel advisories, distributing antiviral stockpiles) are continually lagging behind the actual curve of the disease.

---

## 3. Business Objectives

The transition from SymptoMap V1 to V2 is driven by the following strategic business objectives:

1. **Detect Outbreaks Earlier:** Reduce the average time from initial patient presentation to recognized outbreak alert by 70%, utilizing AI-driven anomaly detection on incoming data streams.
2. **Improve Situational Awareness:** Provide a single, unified source of truth for disease activity across local, regional, and national levels through real-time geospatial dashboards.
3. **Support Public Health Decisions:** Deliver actionable intelligence, such as automated risk assessments and resource allocation recommendations, directly to policymakers and hospital administrators.
4. **Enable Real-Time Monitoring:** Transition from static, batched reporting to continuous, real-time data ingestion and visualization via WebSockets and stream processing.
5. **Improve Forecasting Accuracy:** Integrate advanced ML models (SEIR, Prophet, XGBoost) to forecast outbreak trajectories 14, 30, and 60 days into the future with a minimum 85% confidence interval.
6. **Reduce Response Times:** Automate the generation and dissemination of threshold alerts and executive reports, ensuring the right stakeholders are notified instantaneously when critical metrics are breached.

---

## 4. Stakeholder Analysis

### Primary Stakeholders
- **Public Health Authorities (e.g., CDC, WHO, MoH):** Rely on the platform for national and global disease monitoring, policy-making, and resource allocation.
- **Hospitals & Clinics:** Input ground-level data and use the platform to anticipate patient surges, manage ICU bed capacity, and secure medical supplies.
- **Disease Surveillance Teams:** Actively monitor incoming data streams, validate outbreak reports, and coordinate field responses.
- **Epidemiologists:** Utilize the platform's advanced forecasting, historical data analysis, and SEIR modeling tools to study disease patterns.
- **Government Agencies:** Require high-level, executive summaries and risk assessments to manage economic impacts, travel restrictions, and public safety communications.

### Secondary Stakeholders
- **Researchers & Academia:** Utilize anonymized, historical datasets exported from the platform for epidemiological studies and publication.
- **NGOs (Non-Governmental Organizations):** Use the data to target relief efforts, deploy medical camps, and allocate funding to high-risk zones.
- **Healthcare Administrators:** Monitor operational impacts of outbreaks on healthcare networks and supply chains.
- **Data Analysts / Data Scientists:** Build and refine the underlying machine learning models and integrate external data sources (e.g., weather, mobility data).

---

## 5. User Personas

### 1. Dr. Elena Rostova - Epidemiologist
- **Goals:** To accurately model the spread of emerging infectious diseases and understand the efficacy of public health interventions.
- **Challenges:** Existing tools require manual data cleaning; lack of integrated, real-time data feeds; difficulty in running complex simulations at scale.
- **Responsibilities:** Developing epidemiological models, analyzing historical trends, advising public health policy.
- **Platform Usage:** Interacting with the Forecasting Dashboard, adjusting SEIR model parameters, analyzing geographic clustering, and exporting large datasets for advanced statistical analysis.

### 2. Marcus Chen - Public Health Officer
- **Goals:** To rapidly identify local health threats and coordinate immediate, effective community responses.
- **Challenges:** Overwhelmed by false alarms; delayed reporting from rural clinics; lack of clear visualization of affected zones.
- **Responsibilities:** Monitoring regional dashboards, investigating anomalies, issuing localized health advisories, coordinating with local hospitals.
- **Platform Usage:** Utilizing the Alert Dashboard, reviewing real-time geospatial heatmaps, setting threshold alerts for specific symptoms or diseases within his jurisdiction.

### 3. Sarah Jenkins - Hospital Administrator
- **Goals:** To ensure the hospital has adequate staff, beds, and supplies to handle incoming patient surges.
- **Challenges:** Unpredictable patient volumes; lack of visibility into broader regional health trends that might impact her facility.
- **Responsibilities:** Resource management, staff scheduling, budget allocation.
- **Platform Usage:** Viewing the Risk Dashboard to anticipate surges, monitoring local outbreak proximity to the hospital, and receiving automated threshold alerts regarding regional bed capacity threats.

### 4. David Alaba - Disease Surveillance Analyst
- **Goals:** To validate incoming disease reports and maintain the integrity of the surveillance data.
- **Challenges:** High volume of noisy data; manual verification processes; integrating data from diverse, unstructured sources.
- **Responsibilities:** Triaging automated alerts, verifying clinical reports, cleaning data, generating weekly surveillance reports.
- **Platform Usage:** Using the core Disease Surveillance interface to review incoming case data, manage alerts, and utilize AI summarization to quickly understand qualitative outbreak descriptions.

### 5. Minister Amina Diop - Government Decision Maker
- **Goals:** To protect public safety while minimizing economic disruption during health crises.
- **Challenges:** Translating complex epidemiological data into actionable policy; balancing competing priorities; communicating risk clearly to the public.
- **Responsibilities:** Enacting public health mandates, allocating federal budgets, communicating with the press.
- **Platform Usage:** Viewing the Executive Dashboard for high-level summaries, AI-generated risk assessments, and automated executive reports indicating overall national threat levels.

### 6. Dr. Liam O'Connor - Research Scientist
- **Goals:** To study the long-term impact of climate change on vector-borne diseases.
- **Challenges:** Access to high-quality, longitudinal, geocoded health data is heavily restricted or non-existent.
- **Responsibilities:** Publishing peer-reviewed research, developing novel predictive algorithms.
- **Platform Usage:** Querying historical databases, accessing the platform via API, correlating disease incidence with external climate datasets.

---

## 6. Current System Analysis (Version 1 vs. Version 2 Needs)

### Limitations of the Existing System (Version 1)
The V1 architecture of SymptoMap is a functional, yet foundational, proof-of-concept. It allows doctors to submit outbreak forms which are stored in a SQLite database and displayed on a React-based map.
- **Manual Spreadsheets / Static Data:** While V1 eliminated some paper processes, it relies on manual form submission by doctors. There is no automated ingestion from hospital APIs, LIMS, or national registries.
- **Delayed Reporting & Polling:** The current dashboard relies on client-side polling (every 30 seconds). While acceptable for a small-scale demo, this does not scale to an enterprise level and introduces unnecessary server load and latency compared to WebSocket-driven real-time updates.
- **Data Silos & Storage Limitations:** The system uses SQLite, which is entirely inadequate for concurrent write-heavy enterprise workloads, geospatial querying, and large-scale analytical processing. It creates a massive data silo that cannot easily interface with other BI tools.
- **Lack of Predictive Analytics:** V1 is purely reactive. It shows what has *already* happened. There are no ML models, forecasting, or predictive risk assessments to show where the disease will spread *next*.
- **Poor Geographic Visibility:** V1 uses basic map markers. It lacks advanced geospatial capabilities such as PostGIS-powered cluster detection, dynamic heatmaps, and spatial correlation with demographic data.

---

## 7. Proposed Solution: SymptoMap V2

SymptoMap V2 transforms the platform from a simple reporting tool into a massive **Disease Intelligence & Surveillance Platform**. 

- **Disease Intelligence Platform:** Aggregates, cleans, and correlates data from thousands of sources, applying Natural Language Processing (NLP) to unstructured clinical notes and generating automated summaries.
- **Real-Time Surveillance System:** Shifts to an event-driven architecture (e.g., Kafka) and WebSockets, ensuring that an outbreak reported in a rural clinic reflects on the national dashboard in milliseconds.
- **Forecasting Engine:** Introduces a dedicated ML microservice layer running Prophet, XGBoost, and SEIR models, actively predicting disease spread trajectories and resource impacts.
- **Outbreak Monitoring Platform:** Provides sophisticated Alert Management with dynamic thresholding, ensuring stakeholders receive targeted, actionable notifications rather than notification fatigue.
- **Geospatial Intelligence System:** Migrates to PostgreSQL with PostGIS, powering high-fidelity Mapbox interfaces that dynamically render heatmaps, risk zones, and geographic disease clusters.

---

## 8. Functional Requirements

### Disease Surveillance
- **Case Collection:** Support high-throughput ingestion of case data via REST APIs, bulk CSV imports, and HL7/FHIR integrations from hospital EHRs.
- **Disease Monitoring:** Real-time tracking of disease incidence rates, categorized by pathogen, severity, and demographics.
- **Trend Analysis:** Automated calculation of rolling averages, day-over-day, and week-over-week growth rates.
- **Outbreak Detection:** Algorithmic detection of statistically significant deviations from historical baselines to flag potential new outbreaks automatically.

### Geospatial Analytics
- **Heatmaps:** Dynamic generation of density heatmaps based on case volume and severity within a specific bounding box.
- **Disease Clusters:** Automated spatial clustering algorithms (e.g., DBSCAN) to identify concentrated pockets of infection.
- **Risk Zones:** Demarcation of high-risk geographic polygons based on proximity to active clusters and mobility data.
- **Interactive Maps:** Fluid, hardware-accelerated mapping interface allowing users to filter by time, disease, and severity, with drill-down capabilities from country to street level.

### Forecasting
- **SEIR Simulations:** Configurable Susceptible-Exposed-Infectious-Recovered modeling for communicable diseases, allowing epidemiologists to tweak transmission rate ($R_0$) and recovery times.
- **Trend Prediction:** 30-day and 60-day forecasting of case volumes using time-series models.
- **Future Outbreak Estimation:** Predictive algorithms identifying regions at highest risk for *new* outbreaks based on environmental factors, travel vectors, and historical patterns.

### Alert Management
- **Risk Alerts:** Notifications generated when the AI engine upgrades the risk status of a specific region (e.g., "Elevated Risk of Dengue in Region X").
- **Threshold Alerts:** User-configurable alerts triggered when specific metrics are breached (e.g., "Notify me if >50 cases of Cholera are reported within 24 hours in District Y").
- **Emerging Outbreak Notifications:** Immediate push notifications to relevant health officers when a new cluster is algorithmically detected.

### Reporting
- **Weekly/Monthly Reports:** Automated generation of PDF/HTML reports summarizing regional disease activity, trends, and key metrics.
- **Executive Reports:** High-level, AI-summarized briefs designed for government officials, highlighting critical threats and resource requirements without getting bogged down in raw data.

### Role-Based Access (RBAC)
- **Admin:** Full system configuration, user management, and audit log access.
- **Epidemiologist:** Access to raw data extracts, ML model configurations, and advanced forecasting tools.
- **Analyst:** Access to dashboards, data verification tools, and alert configuration.
- **Viewer:** Read-only access to specific dashboards and reports based on geographic or organizational clearance.

---

## 9. Non-Functional Requirements

- **Scalability:** The system must horizontally scale to handle 10,000+ concurrent users and ingest 1,000+ reports per second during a major health crisis.
- **Availability:** 99.99% uptime SLA. The system is mission-critical and must employ multi-region failover and highly available database architectures.
- **Performance:** Dashboard load times must be under 2 seconds. Real-time alerts must be processed and delivered within 100 milliseconds of ingestion. Map interactions (panning, zooming) must render at 60 FPS.
- **Reliability:** Zero data loss guarantee during ingestion. Event queues (e.g., Kafka) must ensure message persistence and at-least-once delivery.
- **Security:** End-to-end encryption. Data at rest using AES-256. Strict RBAC. Compliance with HIPAA, GDPR, and localized health data protection regulations.
- **Maintainability:** Microservices architecture to allow independent deployment of the ML engine, core API, and frontend. Comprehensive unit and integration test coverage (>85%).
- **Usability:** Intuitive UI requiring less than 2 hours of training for non-technical hospital administrators. Adherence to WCAG 2.1 AA accessibility standards.
- **Accessibility:** Must be usable on low-bandwidth connections (e.g., rural clinics) via progressive web app (PWA) optimization and offline-first capabilities for data submission.

---

## 10. Data Sources

To provide comprehensive intelligence, SymptoMap V2 will integrate with:
- **Hospital Reports:** Direct HL7/FHIR integrations with major Electronic Health Record (EHR) systems (e.g., Epic, Cerner).
- **Health Department Data:** Scheduled ingestion of regional health department syndromic surveillance data.
- **Laboratory Results:** Feeds from major diagnostic laboratories confirming pathogen presence.
- **Public Health APIs:** Integration with open health data platforms.
- **WHO Datasets:** Regular syncing with World Health Organization global disease tracking feeds.
- **CDC Datasets:** Ingestion of Center for Disease Control statistics for baseline comparisons.
- **User Submitted Data:** The V1 portal for doctors and clinics without automated EHR integration remains a critical source of ground-truth data.

---

## 11. AI & Machine Learning Requirements

### AI Features
- **Outbreak Summarization:** Large Language Models (LLMs) parse hundreds of qualitative clinical notes and news reports to generate concise, 3-bullet-point summaries of emerging outbreaks.
- **Risk Assessment:** Automated evaluation of an outbreak's threat level based on pathogen lethality, transmission vectors, and local healthcare capacity.
- **Epidemiological Insights:** AI-driven generation of natural language insights explaining *why* an outbreak is occurring (e.g., correlating a spike in Malaria with recent monsoon data).
- **Automated Reporting:** Generative AI constructs comprehensive executive briefs tailored to the reading level and specific interests of the receiving stakeholder.

### Machine Learning Features
- **Forecasting:** Predicting peak infection dates and total case volumes.
- **Trend Prediction:** Identifying non-linear growth patterns in disease incidence.
- **Disease Spread Modeling:** Simulating the geographic expansion of a cluster over time.

### Models
- **SEIR (Susceptible, Exposed, Infectious, Recovered):** The gold standard for compartmental disease modeling.
- **XGBoost:** Used for risk stratification and classification of outbreak severity based on tabular data.
- **Prophet:** Employed for robust time-series forecasting, specifically handling missing data and weekly/yearly seasonality.
- **Spatial Autoregression Models:** To account for geographic dependencies in disease spread.

---

## 12. Geospatial Intelligence Requirements

### Map Features
- **Disease Hotspots:** Dynamic highlighting of areas exceeding statistical thresholds for disease incidence.
- **Risk Heatmaps:** Visualizing predictive risk—showing where the disease is *likely* to go, not just where it has been.
- **Regional Trends:** Chloropleth maps displaying aggregated data by political boundaries (districts, states, countries).
- **Cluster Detection:** Visual bounding boxes around algorithmically identified clusters of related cases.

### Technologies
- **PostGIS:** Extension for PostgreSQL to perform complex spatial queries (e.g., `ST_Within`, `ST_Distance`) natively at the database level.
- **Mapbox GL JS:** High-performance, WebGL-powered vector maps for the frontend rendering.
- **Geospatial Analytics:** Python libraries (GeoPandas, Shapely) integrated into the backend for spatial clustering and polygon generation.

---

## 13. Dashboard Requirements

SymptoMap V2 utilizes a modular dashboard architecture catering to different personas:

- **Executive Dashboard:** High-level KPIs, macro-trends, AI-generated executive summaries, and national risk levels. Designed for the Minister of Health and high-level decision-makers.
- **Disease Dashboard:** Deep dive into specific pathogens. Displays case counts, mortality rates, demographic breakdowns, and historical comparisons.
- **Forecast Dashboard:** Visualizes SEIR curves, time-series predictions with confidence intervals, and resource impact estimates (e.g., predicted ICU bed shortages).
- **Risk Dashboard:** Matrix of regions and their current threat levels. Highlights areas nearing critical thresholds and suggests preemptive actions.
- **Geospatial Dashboard:** The core mapping interface. Full-screen map with layered toggles for heatmaps, clusters, facilities, and active outbreaks.
- **Alert Dashboard:** A unified inbox for all system-generated warnings, threshold breaches, and anomaly detections. Includes workflow tools to triage, investigate, and dismiss alerts.

---

## 14. Security Requirements

- **Authentication:** OAuth2.0 / OpenID Connect. Integration with enterprise Identity Providers (IdP) via SAML for SSO. Multi-Factor Authentication (MFA) enforcement.
- **Authorization:** Fine-grained, Role-Based Access Control (RBAC). Data-level access controls (e.g., a regional officer can only view PII for their specific district).
- **Audit Logging:** Immutable audit trails for all actions—logins, data exports, alert acknowledgments, and configuration changes. Stored in a highly secure, append-only datastore.
- **Data Encryption:** TLS 1.3 for all data in transit. AES-256 encryption for data at rest. Field-level encryption for Highly Sensitive Data (e.g., specific patient locations if collected).
- **Access Controls:** Network-level security including WAF (Web Application Firewall), DDoS protection, and strict CORS policies.
- **Compliance Considerations:** Architecture designed to comply with HIPAA (USA), GDPR (Europe), and localized healthcare data privacy laws. All PII (Personally Identifiable Information) must be strictly anonymized before being used in ML training or aggregated dashboards.

---

## 15. Risk Assessment

### Business Risks
- **Low Adoption Rates:** Hospitals may refuse to integrate or doctors may find the system too complex. *Mitigation:* Focus heavily on UI/UX and provide automated EHR integrations to reduce manual work.
- **Funding Shortfalls:** Enterprise-grade AI and cloud infrastructure are expensive. *Mitigation:* Demonstrate immediate ROI through cost-savings in outbreak containment to secure government/NGO funding.

### Technical Risks
- **Data Quality & Noise:** Garbage in, garbage out. High volumes of false reports could skew ML models. *Mitigation:* Implement robust anomaly detection and require validation by Surveillance Analysts before data affects core models.
- **System Overload:** Unprecedented traffic during a major pandemic. *Mitigation:* Employ auto-scaling Kubernetes clusters and aggressive edge caching via CDNs.

### Operational Risks
- **False Positives:** Alert fatigue among public health officers due to hypersensitive anomaly detection. *Mitigation:* Continuously tune ML thresholds and allow user-defined alert sensitivities.

### Data Risks
- **Data Breaches:** Exposure of sensitive epidemiological data. *Mitigation:* Regular third-party penetration testing and strict adherence to the Security Requirements (Section 14).

### AI Risks
- **Algorithmic Bias:** ML models trained on biased historical data may fail to accurately predict outbreaks in underrepresented demographic areas. *Mitigation:* Regular audits of model fairness and inclusion of diverse datasets.
- **Hallucinations:** LLM-generated summaries creating false narratives. *Mitigation:* Strict grounding of LLMs in retrieved facts (RAG) and prominent disclaimers requiring human verification.

---

## 16. Success Metrics

The success of SymptoMap V2 will be measured against the following KPIs:

- **Outbreak Detection Time:** Decrease from the current baseline (e.g., 14 days) to < 3 days.
- **Forecast Accuracy:** ML predictions matching actual case counts within a 15% margin of error at a 14-day horizon.
- **Dashboard Adoption:** >80% Monthly Active Users (MAU) among registered public health officers.
- **Alert Effectiveness:** < 10% of alerts dismissed as "False Positive/Irrelevant" by users.
- **Data Latency:** Time from data ingestion to dashboard visualization < 500 milliseconds (99th percentile).
- **System Uptime:** 99.99% availability during peak operational hours.

---

## 17. Future Enhancements (Version 3 Vision)

While V2 establishes a world-class surveillance and intelligence platform, V3 will look toward comprehensive planetary health integration:

- **Predictive Disease Intelligence:** Predicting outbreaks months in advance before the first human case occurs.
- **Multi-Country Surveillance:** Cross-border data sharing agreements to track pandemic spread across international lines.
- **Climate Impact Modeling:** Integrating real-time satellite imagery and climate data to model the impact of global warming on vector-borne disease habitats (e.g., mosquito migration).
- **Wastewater Surveillance Integration:** Ingesting municipal wastewater testing data as a leading indicator of viral load in a community.
- **Mobile Applications:** Dedicated native apps for field epidemiologists for offline data collection in remote areas.
- **AI Decision Support:** Moving from predictive (what will happen) to prescriptive (what you should do). AI recommending specific intervention strategies (e.g., "Deploy 10,000 vaccines to District X to prevent a 40% surge in cases").

---

## 18. Business Benefits

Implementing SymptoMap V2 provides immense, quantifiable benefits to society and healthcare infrastructure:

- **Faster Outbreak Detection:** Translates directly to lives saved and exponential reductions in long-term containment costs.
- **Better Forecasting:** Allows hospitals to optimize supply chains (PPE, ventilators, pharmaceuticals) dynamically, avoiding both shortages and costly overstocking.
- **Improved Public Health Response:** Shifts the paradigm from blanket, state-wide lockdowns to highly targeted, localized quarantine and intervention efforts, preserving economic activity.
- **Enhanced Situational Awareness:** Eliminates the fog of war during health crises, ensuring all stakeholders from frontline doctors to the President are operating off the same, accurate data.
- **Data-Driven Decision Making:** Removes politics and guesswork from public health policy, grounding mandates in rigorous, reproducible mathematical models.

---

